Negin Hosseini Rouzbahani

Negin Hosseini Rouzbahani

Auto-generated profile, based on publicly available information

Negin Hosseini Rouzbahani

Department of Immunology, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2022 in Microbial Pathogenesis
Verified
Journal Article
Closed access
EHEbrahim Hazrati
Ebrahim Hazrati
MGMohammad Gholami
Mohammad Gholami
RFRamin Hamidi Farahani
Ramin Hamidi Farahani
KGKhodayar Ghorban
Khodayar Ghorban
MGMorteza Ghayomzadeh
Morteza Ghayomzadeh
NRNegin Hosseini Rouzbahani
Negin Hosseini Rouzbahani

1 September 2020 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MGMohammad Gholami
Mohammad Gholami
NRNeginHosseini Rouzbahani
NeginHosseini Rouzbahani
SSSiamakMirab Samiee
SiamakMirab Samiee
KTKatayoun Tayeri
Katayoun Tayeri
KGKhodayar Ghorban
Khodayar Ghorban
MMMinoo Mohraz
Minoo Mohraz

7 January 2024 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Open access
PDF file
SDSajad Dehnavi
Sajad Dehnavi
MDMaryam Dadmanesh
Maryam Dadmanesh
NRNegin Hosseini Rouzbahani
Negin Hosseini Rouzbahani
MKMahmood Karimi
Mahmood Karimi
AAAli Asadirad
Ali Asadirad
KGKhodayar Ghorban
Khodayar Ghorban
Increasing the efficacy of allergen-specific intranasal immunotherapy (INIT) has recently been the main goal of several studies to establish this route as a safe delivery method through mucosal pathways. In this case, the present study evaluated the potential of INIT using ovalbumin (OVA)-loaded mesenchymal stromal/stem cell (MSC)-derived exosomes (Exo-OVA) in an allergic asthma mouse model. Together with control groups, sensitized Balb/c mice underwent intranasal immunotherapy with Exo-OVA (10 μg OVA per dose) for three consecutive weeks. Serum-specific immunoglobulin E (IgE) levels, transforming growth factor-beta (TGF-β), interleukin (IL)-4, and interferon-gamma (IFN-γ) production by cultured spleen cells, lung histopathologic analysis, and nasopharyngeal lavage fluid cellular examinations were then conducted. The results showed that INIT using Exo-OVA significantly increased IFN-γ and TGF-β secretion, while allergen-specific IgE and IL-4 production were dramatically decreased compared to the control group receiving phosphate-buffered saline. In addition, the eosinophil and total cell counts in the nasopharyngeal lavage fluid were reduced, and inflammatory conditions and cell accumulation in lung tissue were ameliorated. In conclusion, the Exo-OVA improved the INIT efficacy compared to free OVA. Therefore, this formulation could be introduced as an effective approach for immunomodulatory purposes with a shorter treatment duration and reduced side effects.

2 February 2023 in Gene Reports
Verified
Journal Article
Closed access
ASAmir Mohammad Saeedifar
Amir Mohammad Saeedifar
KGKhodayar Ghorban
Khodayar Ghorban
AGAli Ganji
Ali Ganji
GMGhasem Mosayebi
Ghasem Mosayebi
MGMohammad Gholami
Mohammad Gholami
NRNegin Hosseini Rouzbahani
Negin Hosseini Rouzbahani

11 May 2020 in Archives of Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
RFRamin Farahani
Ramin Farahani
MGMohammad Gholami
Mohammad Gholami
EHEbrahim Hazrati
Ebrahim Hazrati
NRNegin Hosseini Rouzbahani
Negin Hosseini Rouzbahani
ZHZia Hejripour
Zia Hejripour
SZSanaz Zargar
Sanaz Zargar
Recently, a novel coronavirus was reported from Wuhan, Hubei Province, China. The novel coronavirus infection was spread from China to other countries, incl ...

23 June 2019 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Open access
PDF file
NRNegin Hosseini Rouzbahani
Negin Hosseini Rouzbahani
SKSaeid Kaviani
Saeid Kaviani
MVMohammad Vasei
Mohammad Vasei
MSMasoud Soleimani
Masoud Soleimani
KAKayhan Azadmanesh
Kayhan Azadmanesh
SSSajjad Shekarchian
Sajjad Shekarchian
C-C chemokine receptor type 5 (CCR5) is a receptor for some pro-inflammatory chemokines which plays important roles in immunological disorder and host responses to infectious agents. Additionally, the prognosis of some immune-mediated diseases in the people who are naturally carrying the CCR5 32bp deletions is optimistic. However, the clinical application of CCR5 32bp mutant cells is very limited due to the rare availability of donors who are homozygous for CCR5 D32. The transfection efficiency of nucleofected placental mesenchymal stem cells derived - human induced pluripotent stem cells (PMSC-hiPSCs) was examined through the evaluation of green fluorescent protein (GFP) expression using flow cytometry. The nucleofected clonal populations were selected using colony picking. The CCR5 gene disrupted clonal populations were evaluated and confirmed by PCR and Sanger sequencing methods. Also, off-target sites were evaluated by the “Loss of a primer binding site” technique. The results of the flow cytometry revealed that among the six applied nucleofection programs for PMSC-iPSCs, the program of A-033 has achieved the best transfection efficiency (27.7%). PCR and then sequencing results confirmed the CCR5 gene was disrupted in two clonal populations of 16 (D6) and 62 (D20) by the Clustered regularly interspaced short palindromic repeats/CRISPR associated nuclease 9 (CRISPR/Cas9) system. The “Loss of a primer binding site” technique showed that no exonic off-target mutations were induced in both CCR5 gene disrupted clonal populations. We establish a CRISPR/Cas9 mediated CCR5 ablated PMSC-hiPSCs without detectable off-target damage. This approach can provide a stable supply of autologous/allogeneic CCR5-disrupted PMSC-hiPSCs that might be a feasible approach for the treatment of immune-mediated diseases.